Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Metabolic Syndrome 1Lymphoma, Non-Hodgkin 1Heart Failure 1Dyslipidemias 1Central Nervous System Neoplasms 1Cardiovascular Diseases 1Cardiotoxicity 1Cardiomyopathies 1

Interventions

Metformin 2Ethinyl Estradiol 2Blood Pressure 2drospirenone and ethinyl estradiol combination 1drospirenone 1Vascular Stiffness 1Ultrasonography 1Triptorelin Pamoate 1Testosterone 1Sugars 1Spironolactone 1Pulse Wave Analysis 1Preoperative Exercise 1Phlebotomy 1Orchiectomy 1Medical History Taking 1Magnetic Resonance Spectroscopy 1Inositol 1Human Growth Hormone 1Hematologic Tests 1Growth Hormone 1Flutamide 1Exercise 1Etanercept 1Electrocardiography 1Echocardiography 1Diet, Reducing 1Diet, Mediterranean 1Diet, Fat-Restricted 1Diet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Metabolic Syndrome × Pulse Wave Analysis × Clear all
NCT07041827 2025-06-27

CLARITY

The Netherlands Cancer Institute

Completed
217 enrolled
Lymphoid

Cardiovascular Diseases, Heart Failure, Lymphoma, Non-Hodgkin, Cardiomyopathies, Metabolic Syndrome, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡